Real Chemistry has appointed Eddie Morton as head of advisory and public affairs for Asia-Pacific, shortly after his departure from GCI Health, where he served as regional managing director.Based in Singapore, Morton will join Real Chemistry’s global senior leadership team and focus on strengthening the healthcare communications firm’s advisory, corporate reputation and public affairs capabilities across the Asia-Pacific region.In his new role, Morton will work with senior healthcare executives on complex business, regulatory, policy and stakeholder issues, helping organisations navigate challenges that extend beyond traditional communications.The appointment comes as Real Chemistry steps up its APAC expansion following its acquisition of Singapore-based Spurwing Communications in July. The deal established Singapore as the US-headquartered company’s first strategic hub in the region and expanded its capabilities in integrated communications, medical affairs and strategic consulting.Real Chemistry already operates globally across areas including analytics, medical communications and advertising. Following the Spurwing acquisition, the company indicated that it planned additional hiring and market expansion as it developed its APAC hub and affiliate network.Morton left GCI Health earlier this month after joining the agency from Sandpiper in March 2025. He subsequently assumed responsibility for the agency’s Asia-Pacific regional leadership following the departure of longtime APAC president Rikki Jones, who moved to AstraZeneca as head of communications for International & EUCA.At GCI Health, Morton oversaw regional growth and operations, working with market leaders and specialists across communications, public affairs and medical strategy.Prior to joining GCI Health, Morton spent more than three years with Sandpiper, where he most recently served as deputy general manager and co-lead for healthcare in Asia-Pacific.His earlier career includes a stint as head of policy and communications at Australia’s Members Health Fund Alliance, as well as journalism roles with Nikkei Asian Review and the South China Morning Post.Morton’s appointment comes as Real Chemistry expands its global advisory proposition. Earlier this year, the company launched RC Resolve, a dedicated offering covering policy and public affairs, corporate strategy and reputation, issues and crisis management, executive communications and organisational transformation.Real Chemistry’s Asia-Pacific expansion is being led by Emma Thompson, founder of Spurwing Communications, who became president of APAC growth following the acquisition. Thompson reports to group president of international growth Kath Harrison.The appointment of Morton adds further senior expertise to Real Chemistry’s regional leadership as the company builds out its healthcare-focused advisory and public affairs business across APAC.

GCI Health, a global healthcare communications agency, has announced two key leadership appointments as it continues to expand its footprint across the Asia-Pacific region and other international markets.Kath Harrison has been appointed to the newly created role of President, International Markets, with a focus on Asia-Pacific, the Middle East, and emerging growth regions. In this role, Harrison will spearhead the agency?ÇÖs strategic expansion and client engagement across dynamic, fast-evolving healthcare landscapes.Joining her leadership team, Eddie Morton has been named Regional Managing Director, Asia-Pacific. Based in Singapore, Morton will work closely with country leads and regional specialists to deepen GCI Health?ÇÖs integrated offering across communications, public affairs, and medical strategy. He will also support Harrison in driving business growth and operational excellence throughout the region.Formerly President, EMEA, Harrison has been instrumental in GCI Health?ÇÖs rapid expansion across Europe and the Middle East. Since relocating to Dubai in 2024, she has led initiatives that have strengthened the agency?ÇÖs presence in the region. Her new appointment reflects GCI Health?ÇÖs ongoing commitment to supporting healthcare transformation in Asia-Pacific and beyond, where demand for strategic healthcare communications is surging across both public and private sectors.?Ç£Increasingly, our global healthcare clients are organizing their business around international markets, where innovation is accelerating and new benchmarks are being set,?Ç¥ said Kristin Cahill, Global CEO, GCI Group. ?Ç£Asia-Pacific remains a major engine of growth and innovation in healthcare. With Kath?ÇÖs visionary leadership and Eddie?ÇÖs deep expertise in the region, we are well-positioned to help shape the future of health for our clients.?Ç¥Morton brings more than a decade of experience in health communications and public affairs across Asia-Pacific. He joins from Sandpiper Health, where he co-led the regional health practice and advised clients on stakeholder engagement, policy strategy, and reputation management. He began his career in journalism before leading government relations and policy at Members Health, the advocacy group for Australia?ÇÖs not-for-profit health insurers. Since transitioning to consultancy, he has guided a wide range of healthcare and life sciences clients in strengthening their voice and influence across the region.?Ç£Asia-Pacific represents one of the most opportunity-rich regions globally, as healthcare evolves from disease treatment to prevention,?Ç¥ said Eddie Morton. ?Ç£I?ÇÖm thrilled to join GCI Health and build on its legacy of excellence, helping our clients connect meaningfully with patients, providers, and systems.?Ç¥As part of this leadership transition, Rikki Jones, current President, Asia-Pacific, will be leaving GCI Health in July to pursue a new opportunity.